FinnAust Mining’s Roderick McIllree discusses their significant company announcements including the Frankfurt listing, £1 million fundraiser, recent Board changes and their high profile appointments in this exclusive interview with DirectorsTalk
Zeus Capital’s Dr Tom McColm discusses Ilika plc in this exclusive interview with DirectorsTalk
Ilika’s Graeme Purdy discusses their product launch at the IDTecheX conference in this exclusive interview with DirectorsTalk
Haydale Graphene Industries’ Ray Gibbs discusses what a pre-preg is and its applications, revenues for Haydale and their collaboration with Huntsman Advanced Materials in this exclusive interview with DirectorsTalk
FairFX Group’s Ian Strafford-Taylor discusses the proposed placing to raise £5.25 million, the investment from Crystal Amber Fund, corporate card segment, marketing channels and their organic expansion strategy in this exclusive interview with DirectorsTalk
W Resources’ Michael Masterman discusses the La Parrilla Tungsten project update, what’s involved in the first phase and the milestones shareholders should be looking out for
Arria NLG’s Matthew Gould discusses their 7th US patent, how this sets them apart from competitors, how work is progressing with Genpact and what to look out for in the coming months in this exclusive interview with DirectorsTalk
Edenville Energy’s Mark Pryor discusses the mining licence granted by the Tanzanian government, what this means for the company, their next steps and moving forward in 2016 in this exclusive interview with DirectorsTalk
Evgen Pharma’s Dr Stephen Franklin discusses obtaining the required approval to start Phase II clinical trial on SFX-01 in this exclusive interview with DirectorsTalk
Motif Bio’s Dr Graham Lumsden discusses the first patient dosed in the Iclaprim Phase III trials in this exclusive interview with DirectorsTalk
© 2025 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
